Publications by authors named "Yusuke Muto"

Claim this Profile
S
Secondary Publication of Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Angiosarcoma 2025.
Yasuhiro Fujisawa, Yasuo Yoshioka, Koji Yoshino, Taku Fujimura, Yoichi Naito, Yusuke Muto

J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.
Emi Yamazaki, Taku Fujimura, Yumi Kambayashi, Manami Takahashi-Watanabe, Kenta Oka, Yusuke Muto

J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition.
Taku Fujimura, Yusuke Muto, Yoshihide Asano

Biomolecules· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review.
Yusuke Muto, Taku Fujimura, Yoshihide Asano

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.
Ryo Amagai, Taku Fujimura, Yumi Kambayashi, Manami Takahashi-Watanabe, Emi Yamazaki, Yusuke Muto

J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to bimekizumab in a patient with generalized pustular psoriasis who developed secondary failure.
Yusuke Muto, Mai Ueki, Yoshihide Asano

Eur J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin health survey on atopic dermatitis among Japanese children: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.
Chikana Kawaguchi, Maki Ozawa, Takanori Hidaka, Keiko Murakami, Mami Ishikuro, Yusuke Muto

Allergol Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory acrodermatitis continua of Hallopeau successfully treated by baricitinib: A case report.
Yusuke Muto, Mai Ueki, Yoshihide Asano

J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of Darier's disease with apremilast and review of reported cases.
Yusuke Muto, Kengo Kinjyo, Yoshihide Asano

J Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocatalytic Hydrogenation of Pyridines and Other Nitrogen-Containing Aromatic Compounds.
Naoki Shida, Yugo Shimizu, Akizumi Yonezawa, Juri Harada, Yuka Furutani, Yusuke Muto

J Am Chem Soc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial.
Taku Fujimura, Koji Yoshino, Hiroshi Kato, Satoshi Fukushima, Shoichiro Ishizuki, Yusuke Muto

Br J Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.
Yusuke Muto, Taku Fujimura, Akira Takahashi, Kenjiro Namikawa, Dai Ogata

J Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes.
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoru Mizuhashi, Takamichi Ito

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis study.
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito

J Dermatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results.
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito

Br J Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous angiosarcoma treated with taxane-based chemoradiotherapy: A multicenter study of 90 Japanese cases.
Taku Fujimura, Sadanori Furudate, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Yusuke Muto

Skin Health Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas.
Kentaro Ohuchi, Ryo Amagai, Tetsuya Ikawa, Yusuke Muto, Yuna Roh

Exp Dermatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma.
Taku Fujimura, Yusuke Muto, Yoshihide Asano

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases.
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito

Acta Derm Venereol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: A case report.
Mayuko Amagai, Maki Ozawa, Ryo Amagai, Kentaro Ohuchi, Yusuke Muto

Dermatol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases.
Ryo Amagai, Yusuke Muto, Hiroshi Kato, Shigeto Matsushita, Takeo Maekawa

Melanoma Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma.
Yusuke Muto, Eijitsu Ryo, Kenjiro Namikawa, Akira Takahashi, Dai Ogata

Pathol Int· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid.
Kentaro Ohuchi, Taku Fujimura, Chunbing Lyu, Ryo Amagai, Yusuke Muto

J Dermatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma.
Yusuke Muto, Taku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, Ryo Amagai

J Dermatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanoma.
Ryo Amagai, Taku Fujimura, Yusuke Muto, Yumi Kambayashi, Sadanori Furudate

Dermatol Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis